A Phase III Trial to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

This study has been completed.

Study NCT00421928 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: January 12, 2007 Last Updated: May 28, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2008
Primary Completion Date:	July 2008 (Final data collection date for primary outcome measure)